stockrow
Friday 6 November 2026
Export CV’s income statement to Excel — free account
CapsoVision, Inc.
CapsoVision, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 million, up 15.3% from fiscal 2024.
- Revenue
- +9.89%
- EPS
- +92.6%
- Free cash flow
- −84.4%
Quarter to June 2026, against a year earlier
6.33
0.13
+2.10%
Follow CV
Alert me
| Dec '24 | Dec '25 | |
|---|---|---|
P/E ratio |
0.00 | 0.00 |
Altman Z-Score |
— | 17.04 |
P/S ratio |
0.67 | 19.37 |
Altman Z″-Score (non-manufacturers) |
(29.09) | (30.12) |
P/FCF ratio |
0.00 | 0.00 |
Beneish M-Score |
— | (3.47) |
P/Operating CF |
(1.77) | (34.15) |
P/B ratio |
0.00 | 19.80 |
Price to Tangible BV |
0.00 | 19.80 |
EV/Sales |
0.58 | 18.62 |
EV/EBITDA |
0.00 | 0.00 |
EV/Operating CF |
(0.32) | (11.04) |
EV/FCF |
(0.32) | (11.00) |
Quick Ratio |
6.29 | 2.85 |
Current Ratio |
8.24 | 3.77 |
Net Debt/EBITDA |
0.48 | 0.41 |
Debt/Assets |
0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 |
Asset Turnover |
0.00 | 0.78 |
Operating CF/Net income |
1.01 | 0.90 |
Capex/Depreciation |
(0.29) | (0.16) |
| 0.00% | 43.55% | |
| 0.00% | (144.79%) | |
ROIC |
0.00% | (506.59%) |
Return on Tangible Assets |
(144.54%) | (196.96%) |
Average Days of Receivables |
62.13 | 67.27 |
Research and Development Expense of Revenue |
128.62% | 135.09% |
Selling, General and Administrative Expense of Revenue |
95.05% | 106.09% |
Intangible Assets out of Total Assets |
0.00 | 0.00 |
Share Based Compensation of Revenue |
1.33% | 6.09% |
Graham Net Nets |
(17.54) | 0.04 |
Graham Number |
0.00 | 0.00 |
Earnings Yield |
(282.26%) | (45.24%) |
Free Cash Flow Yield |
(274.76%) | (8.74%) |
Revenue per Share |
5.82 | 0.55 |
Operating CF per Share |
(9.95) | (0.93) |
Capex per Share |
(0.08) | 0.00 |
Free Cash Flow per Share |
(10.02) | (0.93) |
Cash per Share |
4.61 | 0.41 |
Shareholders Equity per Share |
(64.11) | 0.54 |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
(64.11) | 0.54 |
Free Cash Flow |
(20.24) | (22.95) |
Working Capital |
13.05 | 12.24 |
Capital Expenditures |
(0.15) | (0.09) |
Net Current Asset Value |
(131.47) | 11.77 |
EV/EBIT |
0.00 | 0.00 |
Capex to Sales |
0.01 | 0.01 |
Price to Operating Income |
0.00 | 0.00 |
| Other line items | ||
Depreciation/Fixed assets |
0.72 | 0.93 |
Cash ROIC |
16.84% | (98.21%) |
Accounts Receivable Turnover |
0.00 | 6.03 |
Accounts Payable Turnover |
0.00 | 6.75 |
Inventory Turnover |
0.00 | 2.27 |
Average Days of Payables |
50.82 | 65.38 |
Days of Inventory on Hand |
178.39 | 170.86 |
Average Receivables |
— | 2.25 |
Average Payables |
— | 0.95 |
Average Inventory |
— | 2.81 |
Average Assets |
— | 17.48 |
Average Common Equity |
— | (58.12) |
Columns are period end dates · fundamentals updated 26 Oct 2026